• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与需要机械通气的COVID-19患者预后相关的因素:日本一项单中心观察性研究

Factors associated with the outcome of patients with COVID-19 requiring mechanical ventilation: A single-center observational study in Japan.

作者信息

Deguchi Ryo, Nishimura Tetsuro, Matsuo Kenji, Wakita Fumiaki, Kawamoto Akihiro, Uchida Kenichiro, Yamamoto Hiromasa, Yamada Koichi, Kakeya Hiroshi, Fujii Hiromichi, Shibata Toshihiko, Mizobata Yasumitsu

机构信息

Department of Traumatology and Critical Care Medicine Osaka Metropolitan University Graduate School of Medicine Osaka Japan.

Department of Infection Control Science Osaka Metropolitan University Graduate School of Medicine Osaka Japan.

出版信息

Acute Med Surg. 2023 Jul 8;10(1):e868. doi: 10.1002/ams2.868. eCollection 2023 Jan-Dec.

DOI:10.1002/ams2.868
PMID:37424772
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10329257/
Abstract

AIM

Coronavirus disease (COVID-19) spread worldwide, and was declared as a pandemic by the World Health Organization. Despite numerous studies in the last few years, the factors associated with the outcomes of patients with COVID-19 requiring mechanical ventilation remain unclear. The prediction of ventilator weaning and mortality using the data obtained at the time of intubation could be beneficial for establishing appropriate treatment strategies and obtaining informed consent. In this study, we aimed to clarify the association between patient information at the time of intubation and the outcomes of intubated COVID-19 patients.

METHODS

This retrospective observational study used single-center data from patients with COVID-19. Patients with COVID-19 who were admitted to Osaka Metropolitan University Hospital from April 1, 2020, to March 31, 2022, and under mechanical ventilation were included. The main outcome was defined as the factors related to ventilator weaning; a multivariate analysis was carried out to evaluate the association between patient information at the time of intubation and the outcome.

RESULTS

In total, 146 patients were included in this study. The factors significantly associated with ventilator weaning were age (65-74 years old, adjusted odds ratio [OR], 0.168; 75 years and older, adjusted OR, 0.121), vaccination history (adjusted OR, 5.655), and Sequential Organ Failure Assessment (SOFA) respiration score (adjusted OR, 0.007) at the time of intubation.

CONCLUSION

Age, SOFA respiration score, and COVID-19 vaccination history at the time of intubation could be associated with outcomes in patients with COVID-19 requiring mechanical ventilation.

摘要

目的

冠状病毒病(COVID-19)在全球范围内传播,并被世界卫生组织宣布为大流行病。尽管在过去几年中有大量研究,但与需要机械通气的COVID-19患者预后相关的因素仍不清楚。利用插管时获得的数据预测呼吸机撤机和死亡率,可能有助于制定适当的治疗策略并获得知情同意。在本研究中,我们旨在阐明插管时的患者信息与插管的COVID-19患者预后之间的关联。

方法

这项回顾性观察研究使用了来自COVID-19患者的单中心数据。纳入了2020年4月1日至2022年3月31日期间入住大阪医科大学医院并接受机械通气的COVID-19患者。主要结局定义为与呼吸机撤机相关的因素;进行多因素分析以评估插管时的患者信息与结局之间的关联。

结果

本研究共纳入146例患者。与呼吸机撤机显著相关的因素包括插管时的年龄(65 - 74岁,调整优势比[OR],0.168;75岁及以上,调整OR,0.121)、疫苗接种史(调整OR,5.655)和序贯器官衰竭评估(SOFA)呼吸评分(调整OR,0.007)。

结论

插管时的年龄、SOFA呼吸评分和COVID-19疫苗接种史可能与需要机械通气的COVID-19患者的预后相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1744/10329257/06df323a1a2a/AMS2-10-e868-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1744/10329257/06df323a1a2a/AMS2-10-e868-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1744/10329257/06df323a1a2a/AMS2-10-e868-g001.jpg

相似文献

1
Factors associated with the outcome of patients with COVID-19 requiring mechanical ventilation: A single-center observational study in Japan.与需要机械通气的COVID-19患者预后相关的因素:日本一项单中心观察性研究
Acute Med Surg. 2023 Jul 8;10(1):e868. doi: 10.1002/ams2.868. eCollection 2023 Jan-Dec.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Effect of Intubation Timing on the Outcome of Patients With Severe Respiratory Distress Secondary to COVID-19 Pneumonia.气管插管时机对新型冠状病毒肺炎继发严重呼吸窘迫患者预后的影响。
Cureus. 2021 Nov 16;13(11):e19620. doi: 10.7759/cureus.19620. eCollection 2021 Nov.
4
Evaluation of characteristics and prognosis of COVID-19 patients requiring invasive mechanical ventilation during dominance of nonvariant, alpha, delta, and omicron variants in tertiary hospitals of Japan.日本三级医院在非变异株、α变异株、δ变异株和奥密克戎变异株流行期间需要有创机械通气的COVID-19患者的特征及预后评估
BMC Infect Dis. 2024 Feb 20;24(1):223. doi: 10.1186/s12879-024-09131-4.
5
COVID-19 patients in a tertiary US hospital: Assessment of clinical course and predictors of the disease severity.美国一家三级医院的 COVID-19 患者:临床病程评估和疾病严重程度预测因素。
Respir Med. 2020 Oct;172:106130. doi: 10.1016/j.rmed.2020.106130. Epub 2020 Aug 28.
6
Tracheostomy is Safe in Patients with Prolonged Intubation After Coronavirus Disease 2019 Infection.COVID-19 感染后长时间插管的患者行气管切开术是安全的。
J Surg Res. 2021 Oct;266:361-365. doi: 10.1016/j.jss.2021.04.023. Epub 2021 Apr 27.
7
Non-invasive positive pressure ventilation versus endotracheal intubation in treatment of COVID-19 patients requiring ventilatory support.经鼻高流量湿化氧疗与无创通气在新型冠状病毒肺炎患者中的应用比较
Am J Emerg Med. 2021 May;43:103-108. doi: 10.1016/j.ajem.2021.01.068. Epub 2021 Jan 29.
8
Intubation Decision Based on Illness Severity and Mortality in COVID-19: An International Study.基于疾病严重程度和 COVID-19 死亡率的插管决策:一项国际研究。
Crit Care Med. 2024 Jun 1;52(6):930-941. doi: 10.1097/CCM.0000000000006229. Epub 2024 Feb 23.
9
Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.住院 COVID-19 患者的凝血病:治疗性抗凝与标准治疗作为对 COVID-19 大流行的快速反应的实用随机对照试验 (RAPID COVID COAG - RAPID 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 10;22(1):202. doi: 10.1186/s13063-021-05076-0.
10
[Predictors of weaning and mortality in prolonged mechanical ventilation – surviving survival].[长期机械通气患者撤机及死亡的预测因素——生存者的生存情况]
Rev Fac Cien Med Univ Nac Cordoba. 2022 Jun 6;79(2):162-167. doi: 10.31053/1853.0605.v79.n2.33184.

本文引用的文献

1
Relationship Between Preexisting Cardiovascular Disease and Death and Cardiovascular Outcomes in Critically Ill Patients With COVID-19.新冠肺炎危重症患者中既有心血管疾病与死亡和心血管结局的关系。
Circ Cardiovasc Qual Outcomes. 2022 Oct;15(10):e008942. doi: 10.1161/CIRCOUTCOMES.122.008942. Epub 2022 Oct 4.
2
Poor prognosis of patients with severe COVID-19 admitted to an infectious disease intensive care unit during the pandemic caused by the Delta variant in Japan.在日本由德尔塔变异株引发的疫情大流行期间,入住传染病重症监护病房的重症新冠肺炎患者预后较差。
Glob Health Med. 2022 Apr 30;4(2):122-128. doi: 10.35772/ghm.2021.01121.
3
Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis.
接种疫苗以降低新冠病毒感染患者的重症率和死亡率:一项系统评价与荟萃分析
Eur Rev Med Pharmacol Sci. 2022 Mar;26(5):1770-1776. doi: 10.26355/eurrev_202203_28248.
4
COVID-19 and thrombosis: The role of hemodynamics.COVID-19 与血栓:血液动力学的作用。
Thromb Res. 2022 Apr;212:51-57. doi: 10.1016/j.thromres.2022.02.016. Epub 2022 Feb 23.
5
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment.关于具有治疗 SARS-CoV-2(COVID-19)潜力的药物的最新进展。
Drug Resist Updat. 2021 Dec;59:100794. doi: 10.1016/j.drup.2021.100794. Epub 2021 Dec 9.
6
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.莫努匹韦片用于非住院 COVID-19 患者的口服治疗。
N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16.
7
Clinical efficacy and adverse events of baricitinib treatment for coronavirus disease-2019 (COVID-19): A systematic review and meta-analysis.巴瑞替尼治疗 2019 冠状病毒病(COVID-19)的临床疗效和不良事件:系统评价和荟萃分析。
J Med Virol. 2022 Apr;94(4):1523-1534. doi: 10.1002/jmv.27482. Epub 2021 Dec 13.
8
Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.COVID-19 相关死亡风险因素:42 项研究和 423117 例患者的系统评价和荟萃分析。
BMC Infect Dis. 2021 Aug 21;21(1):855. doi: 10.1186/s12879-021-06536-3.
9
Simple prognostic factors and change of inflammatory markers in patients with severe coronavirus disease 2019: a single-center observational study.2019年冠状病毒病重症患者的简单预后因素及炎症标志物变化:一项单中心观察性研究
Acute Med Surg. 2021 Jul 12;8(1):e683. doi: 10.1002/ams2.683. eCollection 2021 Jan-Dec.
10
Prognostic factors for adverse outcomes in patients with COVID-19: a field-wide systematic review and meta-analysis.COVID-19 患者不良结局的预后因素:一项全领域系统回顾和荟萃分析。
Eur Respir J. 2022 Feb 3;59(2). doi: 10.1183/13993003.02964-2020. Print 2022 Feb.